×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AMLX – amylyx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AMLX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/28
06:40 pm
amlx
HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Medium
Report
HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
11/13
02:40 pm
amlx
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
Low
Report
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
11/11
06:00 pm
amlx
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
Medium
Report
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
11/10
05:38 am
amlx
Amylyx Pharmaceuticals (AMLX): Assessing Valuation After a Sharp Rally and Recent Pullback [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals (AMLX): Assessing Valuation After a Sharp Rally and Recent Pullback [Yahoo! Finance]
11/7
03:01 pm
amlx
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at HC Wainwright from $16.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at HC Wainwright from $16.00 to $20.00. They now have a "buy" rating on the stock.
11/6
10:28 am
amlx
Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf
Low
Report
Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf
11/6
07:00 am
amlx
Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
High
Report
Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
11/3
09:00 am
amlx
Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences
Low
Report
Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
07:00 am
AMLX
amylyx pharmaceuticals, inc.
BEAT
Report
-11.2%
amylyx pharmaceuticals, inc.
8/7/2025
07:00 am
AMLX
amylyx pharmaceuticals, inc.
MISS
Report
-6.7%
amylyx pharmaceuticals, inc.
5/8/2025
07:00 am
AMLX
amylyx pharmaceuticals, inc.
BEAT
Report
-6.0%
amylyx pharmaceuticals, inc.
3/4/2025
06:00 am
AMLX
amylyx pharmaceuticals, inc.
MISS
Report
-4.1%
amylyx pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/3
04:40 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Dec 01 Filed by: Bedrosian Camille L
Low
Report
Form 4 Amylyx Pharmaceuticals, For: Dec 01 Filed by: Bedrosian Camille L
12/1
04:05 pm
amlx
Form 144 Amylyx Pharmaceuticals, Filed by: Bedrosian Camille L
Medium
Report
Form 144 Amylyx Pharmaceuticals, Filed by: Bedrosian Camille L
11/17
05:39 pm
amlx
Form SCHEDULE 13G Amylyx Pharmaceuticals, Filed by: Commodore Capital LP
Low
Report
Form SCHEDULE 13G Amylyx Pharmaceuticals, Filed by: Commodore Capital LP
11/14
04:14 pm
amlx
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
High
Report
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
11/14
04:00 pm
amlx
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: PERCEPTIVE ADVISORS LLC
High
Report
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: PERCEPTIVE ADVISORS LLC
11/13
09:06 am
amlx
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: Adage Capital Management, L.P.
Low
Report
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: Adage Capital Management, L.P.
11/6
07:12 am
amlx
Form 10-Q Amylyx Pharmaceuticals, For: Sep 30
High
Report
Form 10-Q Amylyx Pharmaceuticals, For: Sep 30
11/6
07:04 am
amlx
Form 8-K Amylyx Pharmaceuticals, For: Nov 06
High
Report
Form 8-K Amylyx Pharmaceuticals, For: Nov 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: